30 studies found for: Open Studies | "Herpes Simplex"
Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
|3||Not yet recruiting||
A Multiple Ascending Dose-Finding Pharmacokinetic and Pharmacodynamic Study of a Novel Antiviral Drug in Infants With Neonatal Herpes Simplex Virus (HSV)
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?
Palatability Testing of a New Paediatric Formulation of Valacyclovir - VALID 0
30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding
Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of VZV and HSV Infections in Children, Phase I (VALID I)
Interferon Responses in Eczema Herpeticum (ADEH)
Improving Blood Safety and HIV Testing in Brazil
A Methadone Maintenance Treatment Outcome Study in Three Provinces in China
Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals With Herpes Simplex Virus Type 2?
Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes
Herpes Simplex Type 1 Suppression in Hepatitis C
TK008: Efficacy Study on the Strategy of Herpes Simplex Virus Thymidine Kinase Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
|20||Not yet recruiting||
Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection
† Indicates status has not been verified in more than two years